Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,322Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Apotex Inc

02 16Gilead Sciences

03 3Janssen-Cilag

04 1Johnson & Johnson Innovative Medicine

05 1Laurus Labs

06 2Lupin Ltd

07 1Reliv Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : TENOFOVIR ALAFENAMIDE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2024-03-21

Application Number : 213867

Regulatory Info : DISCN

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 120MG;EQ 15MG BASE

Packaging :

Approval Date : 2024-05-17

Application Number : 214053

Regulatory Info : DISCN

Registration Country : USA

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG;EQ 25MG BASE

Packaging :

Approval Date : 2024-05-17

Application Number : 214053

Regulatory Info : DISCN

Registration Country : USA

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : GENVOYA

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;150MG;200MG;EQ 10MG BASE

Packaging :

Approval Date : 2015-11-05

Application Number : 207561

Regulatory Info : RX

Registration Country : USA

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : DESCOVY

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG;EQ 25MG BASE

Packaging :

Approval Date : 2016-04-04

Application Number : 208215

Regulatory Info : RX

Registration Country : USA

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : DESCOVY

Dosage Form : TABLET;ORAL

Dosage Strength : 120MG;EQ 15MG BASE

Packaging :

Approval Date : 2022-01-07

Application Number : 208215

Regulatory Info : RX

Registration Country : USA

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : ODEFSEY

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG;EQ 25MG BASE;EQ 25MG BASE

Packaging :

Approval Date : 2016-03-01

Application Number : 208351

Regulatory Info : RX

Registration Country : USA

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : VEMLIDY

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2016-11-10

Application Number : 208464

Regulatory Info : RX

Registration Country : USA

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : BIKTARVY

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 50MG BASE;200MG;EQ 25MG BASE

Packaging :

Approval Date : 2018-02-07

Application Number : 210251

Regulatory Info : RX

Registration Country : USA

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : BIKTARVY

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 30MG BASE;120MG;EQ 15MG BASE

Packaging :

Approval Date : 2021-10-07

Application Number : 210251

Regulatory Info : RX

Registration Country : USA

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Hemifumarate

Brand Name : Confessional View

Dosage Form : Film Coated Tablet

Dosage Strength : 30mg;120mg;15mg

Packaging :

Approval Date : 21/11/2022

Application Number : 20210531000118

Regulatory Info : Approved

Registration Country : Sweden

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Hemifumarate

Brand Name : Confessional View

Dosage Form : Film Coated Tablet

Dosage Strength : 50mg;200mg;25mg

Packaging :

Approval Date : 21/06/2018

Application Number : 20170622000024

Regulatory Info : Approved

Registration Country : Sweden

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Elvitegravir; Emtricitabine; Cobicistat; Tenofovir Alafenamide Hemifumarate

Brand Name : Genvoya

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg;150mg;200mg;10mg

Packaging :

Approval Date : 19/11/2015

Application Number : 20141231000187

Regulatory Info : Approved

Registration Country : Sweden

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Elvitegravir; Emtricitabine; Cobicistat; Tenofovir Alafenamide Hemifumarate

Brand Name : Genvoya

Dosage Form : Film Coated Tablet

Dosage Strength : 90mg;90mg;120mg;6mg

Packaging :

Approval Date : 03/10/2022

Application Number : 20210531000101

Regulatory Info : Approved

Registration Country : Sweden

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Darunavir Ethanolate; Emtricitabine; Cobicistat; Tenofovir Alafenamide Hemifumarate

Brand Name : Symtuza

Dosage Form : Film Coated Tablet

Dosage Strength : 800mg;150mg;200mg;10mg

Packaging :

Approval Date : 21/09/2017

Application Number : 20160915000046

Regulatory Info : Approved

Registration Country : Sweden

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : SYMTUZA

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;800MG;200MG;EQ 10MG BASE

Packaging :

Approval Date : 2018-07-17

Application Number : 210455

Regulatory Info : RX

Registration Country : USA

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : TENOFOVIR ALAFENAMIDE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date :

Application Number : 214030

Regulatory Info :

Registration Country : USA

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG;EQ 25MG BASE

Packaging :

Approval Date : 2024-12-13

Application Number : 213926

Regulatory Info : RX

Registration Country : USA

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TENOFOVIR ALAFENAMIDE FUMARATE

Brand Name : TENOFOVIR ALAFENAMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2023-03-30

Application Number : 214226

Regulatory Info : RX

Registration Country : USA

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Tenofovir Alafenamide Fumarate

Brand Name : HEPA-TAF

Dosage Form : Enteric Coated Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Vietnam

blank